Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Roche”
- A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Alzheimer's Disease
Chile, Denmark, France, Germany, Italy +4 more
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis · Primary Progressive Multiple Sclerosis
United States, Brazil, Czechia, Italy, New Zealand +3 more
Sponsor: Hoffmann-La Roche
Neuromyelitis Optica Spectrum Disorder · NMOSD
United States, Argentina, China, France, Italy +4 more
- Obinutuzumab in Primary MNCompleted
Sponsor: Mario Negri Institute for Pharmacological Research
Membranous Nephropathy
Italy
Sponsor: Tel-Aviv Sourasky Medical Center
Follicular Lymphoma
Israel
- A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical TrialActive Not Recruiting
Sponsor: Hoffmann-La Roche
Solid Tumors
Brazil, China, Costa Rica, France, Germany +10 more
- Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell LymphomaActive Not Recruiting
Sponsor: Canadian Cancer Trials Group
Lymphoma
Canada
- PopSci CHW4CervixHealthRecruiting
Sponsor: Thomas Jefferson University
Cervical Cancer · Hpv · Human Papilloma Virus · HPV Infection
United States
- A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or OverweightActive Not Recruiting
Sponsor: Hoffmann-La Roche
Healthy Volunteers · Overweight or Obesity
China
- A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell CarcinomaActive Not Recruiting
Sponsor: Hoffmann-La Roche
Renal Cell Carcinoma
United States, Australia, China, France, Germany +4 more
- An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care TreatmentActive Not Recruiting
Sponsor: Hoffmann-La Roche
Von Willebrand Disease, Type 3
United States, Belgium, Canada, Colombia, France +9 more
Sponsor: Hoffmann-La Roche
Geographic Atrophy · Age-related Macular Degeneration
United States
- Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Diabetic Macular Edema · Neovascular Age-related Macular Degeneration · Retinal Vein Occlusion
China
- GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's DiseaseActive Not Recruiting
Sponsor: Hoffmann-La Roche
Huntington Disease
United States, Argentina, Australia, Austria, Canada +10 more
- A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic DermatitisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Atopic Dermatitis
United States, Brazil, Canada, France, Germany +3 more
Sponsor: Treos Bio Limited
Colorectal Cancer Metastatic
United States
Sponsor: University Hospital, Clermont-Ferrand
HIV Infections
France, Guadeloupe, Reunion
- A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Brazil, France, Germany +4 more
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRecruiting
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Australia, Brazil, Canada +11 more
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Brazil, Canada, China +8 more
- A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple MyelomaActive Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Myeloma
United States, Australia, Belgium, France, Germany +3 more
- A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Muscle-invasive Urothelial Carcinoma
United States, Argentina, Australia, Canada, Denmark +10 more
- A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 DiabetesNot Yet Recruiting
Sponsor: Hoffmann-La Roche
Breast Cancer · Diabetes Type II
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Ulcerative Colitis
United States, Argentina, Australia, Austria, Belgium +25 more
Sponsor: Hoffmann-La Roche
Non-Hodgkin Lymphoma
United States, Argentina, Brazil, Canada, China +8 more